VetPlus colleagues with David Haythornthwaite at World Distributors meeting
Vetplus Continues International Expansion In South America And Africa
4 months ago 
440 views
Global animal nutraceutical expert, VetPlus, is celebrating a successful year after it continued to expand its international distribution network in 2023, appointing its first Distributor in South America.
Distribution of its core range of products, which includes SYNOQUIN®, CALMEX® andAKTIVAIT®, began in Ecuador in May 2022. Since then, further deals have been signed with distributors across six Latin American countries, including Peru, Costa Rica, Guatemala, Chile, Paraguay, Bolivia and Panama, with sales expected to begin in Peru in February 2024.
The success has been driven by a growing VetPlus team in the market, with three employees now based in the VetPlus Regional Support Office in Buenos Aires, Argentina.
Expansion in South America comes alongside a similar period of growth in Africa, where VetPlus currently has distributors in Egypt and Morocco.
In 2023, the business hired its first Business Unit Manager, Kelechi Osuji, based, in Lagos, Nigeria, to support plans to sign its first sub-Saharan distribution partner.
Sam Wright, Sales Director at VetPlus, said: “It’s been a hugely successful year for us as we continue to bring the best in class in veterinary nutraceuticals to vet practices around the world.
“The progress we’ve made in the last 12 months alone is a testament to the hard work of our international team and we have big ambitions to continue expanding both in South America, Africa and beyond.”
VetPlus has been leading the development of nutraceuticals within the UK veterinary profession for over 25 years, with over 3,000 veterinary practices across the country recommending its products.
The news follows another successful year of trading for VetPlus owner, Tangerine Group, which recorded a turnover of £40.9m, up from £37.4m the previous year.
More than £1.6m of the Group’s profits are set to be reinvested back into the business to support further overseas expansion, as well as product development and significant upgrades in manufacturing facilities.
More from VetPlus
